)
Neurogene (NGNE) investor relations material
Neurogene Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Voting matters and shareholder proposals
Election of Class III Directors for terms expiring in 2029, with nominees Robert Baffi, Ph.D. and Rohan Palekar recommended for election.
Advisory (non-binding) vote to approve the compensation of named executive officers.
Advisory (non-binding) vote to ratify Deloitte & Touche LLP as independent registered public accounting firm for the year ending December 31, 2026.
Advisory vote on the frequency of future say-on-pay votes, with a recommendation for every one year.
Proxies are authorized to vote on other business that may properly come before the meeting.
Board of directors and corporate governance
Board recommends the election of two Class III Directors for five-year terms expiring in 2029.
Executive compensation and say-on-pay
Advisory vote proposed to approve the compensation of named executive officers.
Shareholders to vote on the frequency of future say-on-pay votes, with a one-year interval recommended.
- Board recommends approval of all proposals, with detailed governance and compensation disclosures.NGNE
Proxy filing16 Apr 2026 - NGN-401 shows durable, multidomain benefits in Rett syndrome, advancing toward commercialization.NGNE
Corporate presentation24 Mar 2026 - NGN-401 advances with full trial enrollment, FDA Breakthrough status, and strong cash runway.NGNE
Q4 202524 Mar 2026 - Pivotal Rett syndrome gene therapy trial shows strong efficacy, safety, and regulatory momentum.NGNE
Stifel 2026 Virtual CNS Forum18 Mar 2026 - Durable functional gains in Rett syndrome drive NGN-401's pivotal trial and commercial plans.NGNE
Leerink Global Healthcare Conference 20269 Mar 2026 - Phase III Rett gene therapy shows sustained gains, robust safety, and midyear data update ahead.NGNE
TD Cowen 46th Annual Health Care Conference4 Mar 2026 - Pivotal study for NGN-401 in Rett syndrome targets Q2 2026 completion, with strong early efficacy.NGNE
Guggenheim Securities Emerging Outlook: Biotech Summit 202612 Feb 2026 - Accelerated gene therapy development for Rett syndrome, with key data expected Q4 2024.NGNE
Goldman Sachs 45th Annual Global Healthcare Conference3 Feb 2026 - NGN-401 low-dose led to durable, multi-domain gains and strong safety in pediatric Rett syndrome.NGNE
Study Update15 Jan 2026
Next Neurogene earnings date
Next Neurogene earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage